Professor Stephen Johnston

Stephen Johnston is Professor of Breast Cancer Medicine and Consultant Medical Oncologist at the Royal Marsden NHS Foundation Trust & Institute of Cancer Research, London. He is the Clinical Director of the Breast, Lung and Medical Oncology Clinical Business Unit at The Royal Marsden, and was the first Director of the UK’s National Institute for Health Research (NIHR) Biomedical Research Centre for Cancer at The Royal Marsden from 2006-12. He graduated in 1983 from Trinity College at The University of Cambridge, and in 1986 from The Medical School at The University of Newcastle upon Tyne. He trained in General Medicine at St Bartholomew's Hospital and Hammersmith Hospital in London, and subsequently in Medical Oncology at the Royal Marsden Hospital. He gained his PhD from the Institute of Cancer Research at the University of London, and took up his current position as Consultant Medical Oncologist on the Breast Unit at the Royal Marsden Hospital in 1997. He has a specialist interest in the treatment of metastatic breast cancer, and his major research interests lie in understanding mechanisms of endocrine resistance in breast cancer. He is actively involved in facilitating the interface between basic and applied research, and has been chief investigator of several phase II / III trials of novel therapeutic approaches in breast cancer, including new endocrine therapies and targeted signal transduction inhibitors. He has published over 260 breast cancer related articles in peer-reviewed journals, and is a regular invited lecturer at national & international meetings. He is a member of several scientific committees and international advisory boards, has served as Faculty Member at the American Society for Clinical Oncology, Deputy-Editor of the international journal ‘Breast Cancer Research’, and is currently Trustee of the UK charity ‘Walk the Walk’.

Medical Treatment of Metastatic Secondary Breast Cancer (Targeted Therapies, Endocrine Therapies, Biological Therapies, Bone Supportive Therapies, Chemotherapy) Medical Treatment of Early Breast Cancer (Adjuvant Chemotherapy, Adjuvant Endocrine Therapy, Biological Therapies) Clinical Trials in Breast Cancer of novel Endocrine and Targeted Therapies